TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy.

Matthew D Hellmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.